Advances in the Diagnosis, Treatment of Intestinal Cancer: 2nd Edition

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Oncology".

Deadline for manuscript submissions: 28 September 2025 | Viewed by 16

Special Issue Editors

The Division of Data-Driven and Digital Medicine (D3M), Icahn School of Medicine at Mount Sinai, New York, NY, USA
Interests: radiology; deep learning; artificial intelligence; natural language processing; large language models
Special Issues, Collections and Topics in MDPI journals
Department of Gastroenterology, Samson Assuta Ashdod Medical Center, Affiliated with Faculty of Medicine, Ben Gurion University of the Negev, Beersheba, Israel
Interests: gastroenterology; inflammatory bowel disease; diverticular disease; patient health; endoscopy; CRC screening
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Intestinal cancer, also known as colorectal cancer, is one of the leading causes of cancer-related deaths worldwide. Recent advances in the diagnosis and treatment of this disease have improved patient outcomes and increased survival rates.

The early detection of intestinal cancer is crucial for successful treatment, and there have been significant developments in screening and diagnostic techniques.

Treatment options for intestinal cancer have also expanded, with a greater emphasis on personalized and targeted therapies. Surgery remains the primary treatment for early-stage disease, but advancements in surgical techniques, such as laparoscopic and robotic-assisted surgery, have improved outcomes and reduced recovery times. For more advanced disease, chemotherapy and radiation therapy have become more effective and better tolerated, and targeted therapies that inhibit specific molecular pathways have shown promising results in clinical trials.

In addition to these clinical advances, there have been significant advances in understanding the genetic and molecular mechanisms underlying intestinal cancer. Identifying specific genetic mutations and alterations in signaling pathways has led to the development of targeted therapies and the potential for personalized treatment approaches. Furthermore, advances in immunotherapy, particularly the use of immune checkpoint inhibitors, have shown promise in treating intestinal cancer.

Overall, advances in the diagnosis and treatment of intestinal cancer have significantly improved patient outcomes and hold promise for continued progress in the field. However, challenges remain, particularly in the areas of early detection and developing effective treatments for advanced disease.

This Special Issue will focus on updated research that addresses the existing challenges in the field to further improve outcomes for patients with intestinal cancer.

Dr. Eyal Klang
Dr. Adi Lahat
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • colorectal cancer
  • early detection
  • treatment
  • immune therapy
  • radiation therapy
  • chemotherapy
  • risk factors
  • improved prognosis

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Related Special Issue

Published Papers

This special issue is now open for submission.
Back to TopTop